Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg, (a) 90-count bottle (NDC 0378-6322-77), (b) 500-count bottles (NDC 0378-6322-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.

D-0329-2019

December 04, 2018

Class II

Product summary

Firm
Mylan Laboratories Limited, (Nashik FDF)
Event
Event 81707
Status
Ongoing
Classification
Class II
Quantity
50,595 HDPE bottles
Official record key
drug-enforcement:D-0329-2019

Official wording

Reason: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Code information: Lot numbers: 2008880 3084358 3084359 3093801 3084359 3084361 3093801

Distribution pattern: Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodiethylamine (NDEA